This article is more than 5 years old. Information may no longer be current.

FDA approves vaccines for 2011-2012 influenza season

Issue: August 2011

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA announced that it has approved the influenza vaccine formulation to be used for the upcoming 2011-2012 season, according to a press release.

The six brand names and manufacturers approved for the season are Afluria (CSL Limited); Fluarix (GlaxoSmithKline); FluLaval (ID Biomedical Corp.); FluMist (MedImmune); Fluvirin (Novartis Vaccines and Diagnostics Limited); and Fluzone, Fluzone High-Dose and Fluzone Intradermal (Sanofi-Pasteur).

The Fluzone vaccine will be available for those aged 18 to 64 years.

The strains selected for the vaccine are A/California/7/09 (H1N1)-like virus (pandemic (H1N1) 2009 influenza virus, A/Perth /16/2009 (H3N2)-like virus and B/Brisbane/60/2008-like virus.

For more information, please visit the FDA website.

Follow the PediatricSuperSite.com on Twitter.